Evaluation of Phytoconstituents Swertia chirayita for its Antidiabetic properties

Abstract

Swertia chirayita is a medicinal plant with a rich history in traditional Ayurvedic medicine. This article explores the various bioactive compounds present in Swertia chirayita, such as flavonoids and terpenoids. These compounds are thought to be responsible for the plant's noted antioxidant, anti-diabetic, antibacterial, and anticancer properties. A qualitative phytochemical screening in this study revealed significant secondary metabolites in Swertia chirayita, including flavonoids, phenols, saponins, glycosides, and tannins, which are considered important secondary metabolites of the plant. The initial screening process detected various substances in the extracts, including alkaloids, carbohydrates, glycosides, proteins, phenols, flavonoids, saponins, terpenoids, tannins, and steroids. These active metabolites are well-documented for their efficacy in addressing various human ailments, including menstrual disorders, chronic eczema, diarrhoea, dysentery, spasmodic conditions, and as diuretic-choleretic agents. Swertia Chirayata extracts from Swertia chirayata may help manage diabetes. It was corroborated by the fact that Swertia chirayata inhibited α-amylase activity at 59.36 ± 1.42 µg/ml and α-glucosidase activity at 28.12 ± 1.34 µg/ml. In summary, the antidiabetic qualities of Swertia chirayata make them potential candidates for a functional food or natural supplement.  The antibacterial, antidiabetic, and antioxidant properties of Swertia chirayita may be attributed to the primary phytochemical components identified in this investigation. The preliminary findings indicate a need for further research, including in vitro studies. Consequently, Swertia chirayita, examined in this study, may have valuable applications in the pharmaceutical industry for various medical uses. Finally, the limitations of current research and the need for further studies are addressed.